Gene · 4830
Papers3,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative analysis reveals methylenetetrahydrofolate dehydrogenase 1-like as an independent shared diagnostic and prognostic biomarker in five different human cancers. | Biosci Rep | 2022 | 34908119 | PubTator, text mining | PubMed |
| Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma. | J Clin Invest | 2022 | 34882582 | PubTator, text mining | PubMed |
| The impact of genetic variations in sofosbuvir metabolizing enzymes and innate immunity mediators on treatment outcome in HCV-infected patients. | Microb Pathog | 2022 | 34843922 | PubTator, text mining | PubMed |
| Genomic comparisons between hepatocarcinogenic and non-hepatocarcinogenic organophosphate insecticides in the mouse liver. | Toxicology | 2022 | 34813904 | PubTator, text mining | PubMed |
| NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson's Disease. | Mol Neurobiol | 2022 | 34623600 | PubTator, text mining | PubMed |
| NDK/NME proteins: a host-pathogen interface perspective towards therapeutics. | Curr Genet | 2022 | 34480234 | PubTator, text mining | PubMed |
| Engineered exosomes for co-delivery of PGM5-AS1 and oxaliplatin to reverse drug resistance in colon cancer. | J Cell Physiol | 2022 | 34463962 | PubTator, text mining | PubMed |
| High-Resolution Native Mass Spectrometry. | Chem Rev | 2022 | 34415162 | PubTator, text mining | PubMed |
| IRF6 Regulates the Delivery of E-Cadherin to the Plasma Membrane. | J Invest Dermatol | 2022 | 34310950 | PubTator, text mining | PubMed |
| Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease. | Neural Regen Res | 2022 | 34100424 | PubTator, text mining | PubMed |
| Tumor Necrosis Factor Alpha and the Gastrointestinal Epithelium: Implications for the Gut-Brain Axis and Hypertension. | Cell Mol Neurobiol | 2022 | 33594519 | PubTator, text mining | PubMed |
| Expression, Activity, and Regulation of Phosphorylating Enzymes in Tissues and Cells Relevant to HIV-1 Sexual Transmission. | AIDS Res Hum Retroviruses | 2022 | 33567990 | PubTator, text mining | PubMed |
| A shotgun proteomic approach reveals novel potential salivary protein biomarkers for asthma. | J Asthma | 2022 | 33211619 | PubTator, text mining | PubMed |
| An Integrative Network Approach to Identify Common Genes for the Therapeutics in Tuberculosis and Its Overlapping Non-Communicable Diseases. | Front Pharmacol | 2021 | 35153741 | PubTator, text mining | PubMed |
| Identification of hub genes in key hallmarks of ovarian cancer via bioinformatics analysis. | Transl Cancer Res | 2021 | 35116413 | PubTator, text mining | PubMed |
| Identification of SRXN1 and KRT6A as Key Genes in Smoking-Related Non-Small-Cell Lung Cancer Through Bioinformatics and Functional Analyses. | Front Oncol | 2021 | 35071014 | PubTator, text mining | PubMed |
| Insights Into Amentoflavone: A Natural Multifunctional Biflavonoid. | Front Pharmacol | 2021 | 35002708 | PubTator, text mining | PubMed |
| Clinicopathological and prognostic significance of NM23 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis. | Medicine (Baltimore) | 2021 | 34964763 | PubTator, text mining | PubMed |
| Protein Tyrosine Phosphatases in Neuroblastoma: Emerging Roles as Biomarkers and Therapeutic Targets. | Front Cell Dev Biol | 2021 | 34957126 | PubTator, text mining | PubMed |
| Molecular Targets of Natural Compounds with Anti-Cancer Properties. | Int J Mol Sci | 2021 | 34948455 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4830/papers?page=24